Up regulation of GW112 gene by NFκB promotes an antiapoptotic property in gastric cancer cells

Molecular Carcinogenesis

Volumn 49, Issue 3, 2010, Pages 259-270

  Kim, Kee K ^a,c   Park, Key S ^a   Song, Seok B ^b   Kim, Kyoon E ^a  

^a Chungnam National University   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Apoptosis; B; Gastric cancer; GW112; Nf ; Transcription

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; LUCIFERASE; MESSENGER RNA; OLFM4 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; GW112 GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; UPREGULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TRANSCRIPTION INITIATION SITE; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASES; NF-KAPPA B; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION INITIATION SITE; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77949904601     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20596     Document Type: Article

References (44)

1. Shinozaki S, Nakamura T, Iimura M, et al. Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut 2001;48:623-629.
2. Zhang J, Liu WL, Tang DC, et al. Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 2002;283:83-93.
3. Zhang X, Huang Q, Yang Z, Li Y, Li CY. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 2004;64:2474-2481.
4. Takenawa H, Kurosaki M, Enomoto N, et al. Differential gene-expression profiles associated with gastric adenoma. Br J Cancer 2004;90:216-223.
5. Wentzensen N, Wilz B, Findeisen P, et al. Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. Int J Oncol 2004;24:987-994.
6. Aung PP, Oue N, Mitani Y, et al. Systematic search for gastric cancer-specific genes based on SAGE data: Melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2006;25:2546-2557.
7. Conrotto P, Roesli C, Rybak J, et al. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer 2008;123:2856-2864.
8. Cusack JC, Jr., Liu R, Houston M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: Implications for systemic nuclear factor-kappaB inhibition. Cancer Res 2001;61:3535-3540.
9. Gerondakis S, Grumont R, Gugasyan R, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006;25:6781-6799.
10. Schwartz SA, Hernandez A, Mark Evers B. The role of NF-kappaB/IkappaB proteins in cancer: Implications for novel treatment strategies. Surg Oncol 1999;8:143-153.
11. Aggarwal BB. Apoptosis and nuclear factor-kappa B: A tale of association and dissociation. Biochem Pharmacol 2000;60:1033-1039.
12. Arlt A, Gehrz A, Muerkoster S, et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene2003;22:3243-3251.
13. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J Am Soc Nephrol 2003;14:1427-1434.
14. Schoderbek WE, Kim KE, Ridgway EC, Mellon PL, Maurer RA. Analysis of DNA sequences required for pituitary-specific expression of the glycoprotein hormone alpha-subunit gene. Mol Endocrinol 1992;6:893-903.
15. Song SB, Rhee M, Roberson MS, Maurer RA, Kim KE. Gonadotropin-releasing hormone-induced stimulation of the rat secretogranin II promoter involves activation of CREB. Mol Cell Endocrinol 2003;199:29-36.
16. Kaiser UB, Sabbagh E, Katzenellenbogen RA, Conn PM, Chin WW. A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone. Proc Natl Acad Sci USA 1995;92:12280-12284.
17. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 1987;7:725-737. (Pubitemid 17004537)
18. Edlund T, Walker MD, Barr PJ, Rutter WJ. Cell-specific expression of the rat insulin gene: Evidence for role of two distinct 5′ flanking elements. Science 1985;230:912-916.
19. Kim BY, Kim KA, Kwon O, et al. NF-kappaB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis 2005;26:1395-1403.
20. He L, Kim BY, Kim KA, et al. NF-kappaB inhibition enhances caspase-3 degradation of Akt1 and apoptosis in response to camptothecin. Cell Signal 2007;19:1713-1721.
21. Wingender E. Compilation of transcription regulating proteins. Nucleic Acids Res 1988;16:1879-1902.
22. Kim H, Seo JY, Kim KH. Effects of mannitol and dimethylthiourea on helicobacter pylori-induced IL-8 production in gastric epithelial cells. Pharmacology 1999;59:201-211.
23. Kim H, Seo JY, Kim KH. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci 2000;45:621-628.
24. Lim JW, Kim H, Kim KH. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest J Tech Methods Pathol 2001;81:349-360.
25. Sasaki N, Morisaki T, Hashizume K, et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001;7:4136-4142.
26. Rosenbauer F, Wagner K, Zhang P, Knobeloch KP, Iwama A, Tenen DG. pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. Blood 2004;103:4294-4301.
27. Simon MC. PU.1 and hematopoiesis: Lessons learned from gene targeting experiments. Semin Immunol 1998;10:111-118.
28. Lloberas J, Soler C, Celada A. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol Today 1999;20:184-189.
29. Emili A, Greenblatt J, Ingles CJ. Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol 1994;14:1582-1593.
30. Hagemeier C, Bannister AJ, Cook A, Kouzarides T. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 1993;90:1580-1584.
31. Kihara-Negishi F, Yamamoto H, Suzuki M, et al. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Oncogene 2001;20:6039-6047.
32. Burke TW, Kadonaga JT. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 1997;11:3020-3031.
33. Usheva A, Shenk T. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell 1994;76:1115-1121.
34. Smale ST, Kadonaga JT. The RNA polymerase II core promoter. Annu Rev Biochem 2003;72:449-479.
35. Chin KL, Aerbajinai W, Zhu J, et al. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 2008;143:421-432.
36. Baek D, Davis C, Ewing B, Gordon D, Green P. Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. Genome Res 2007;17:145-155.
37. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH. The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 2008;24:167-177.
38. Ayoubi TA, Van De Ven WJ. Regulation of gene expression by alternative promoters. FASEB J 1996;10:453-460.
39. Liu W, Chen L, Zhu J, Rodgers GP. The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res 2006;312:1785-1797.
40. Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC. Osteopontin: It's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life 2005;57:441-447.
41. von Wnuck Lipinski K, Keul P, Ferri N, et al. Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circ Res 2006;98:1490-1497.
42. Pacifico F, Leonardi A. NF-kappaB in solid tumors. Biochem Pharmacol 2006;72:1142-1152.
43. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17:3629-3639.
44. Fan XM, Wong BC, Wang WP, et al. Inhibition of proteasome function induced apoptosis in gastric cancer. Int J Cancer 2001;93:481-488.